References in periodicals archive ?
Demographic features and GMFCS levels of the patients Group 1 (n=19) Group 2 (n=19) n Mean[+ or -]SD n Mean[+ or -]SD Age (year) 6.1[+ or -]2.2 6.5[+ or -]2.1 Gender (*) Female 11 8 Male 8 11 BMI (kg/[m.sup.2]) ([dagger]) 14.8[+ or -]1.8 14.5[+ or -]1.9 GMFCS level 1 5 4 GMFCS level 2 5 4 GMFCS level 3 9 11 p Age (year) 0.552 Gender (*) 0.330 Female Male BMI (kg/[m.sup.2]) ([dagger]) 0.452 GMFCS level 1 GMFCS level 2 GMFCS level 3 GMFCS: Gross Motor Function Classification System; SD: Standard deviation.
De maneira analoga pacientes com GMFCS IV e V apresentam menores valores de DMO em membros inferiores (Chen e colaboradores, 2011; Kilpinen-Loisa e colaboradores, 2010) quando comparados aos niveis menos comprometidos de funcao motora.
A total of 30 sessions of RR was scheduled for the children with CP who were at GMFCS level 2-4, had received no botulinum toxin injections or surgical treatment within the previous 3 months, had sufficient mental function and did not have treatment-resistant epilepsy, any sight or hearing problem, contracture of the lower extremity, fracture or joint instability, hip dislocation or any circulation problems.
Both the spastic motor and quadriplegic sub-types of CP showed a high affinity for Level V of the GMFCS: 58.1% and 62.3% respectively.
More affected upper extremity Left Right All Age 9y 5m (3y) 9y 1m (2y 11m) 9y 3m (2y 11m) Gender (n) Female 9 24 33 Male 21 21 42 Lesion timing (n) Brain malformation 4 2 6 Periventricular white 14 17 31 matter lesion Cortical/subcortical 10 22 32 lesion NA 2 4 6 MACS (level) Level I 7 9 16 Level II 22 28 50 Level III 1 8 9 GMFCS (level) Level I 27 37 64 Level II 3 8 11 Total (n) 30 45 75 MACS: Manual Ability Classification System; GMFCS: Global Motor Function Classification System.
Patients with CP were more frequently classified into levels II (n=25) and III (n=13) of the GMFCS; other patients were classified into levels IV (n=9) and V (n=12).
According to Palisano et al., classification of gross motor function is based on the Gross Motor Function Classification System (GMFCS) as follows: level I and II indicate ability to walk unaided, level III pertains to walking with hand-held support or assistance, while individuals classified at level IV and V are unable to walk [3-5].
In relation to the ability of independent movement of the child, we divided mothers into two groups: mothers of children who can move independently (Gross Motor Function Classification System, GMF-CS I, II and III) and mothers of children who cannot move independently (GMFCS IV and V).
The relationship between risk factors, accompanying problems, and intellectual level was analyzed by the chi squared test; and the relationship between BFMF, GMFCS, and cognitive level, was analyzed by Spearman's correlation test.
(F/M) 22 (18/4) Baseline age (years) 6.42 [+ or -] 1.74 (mean [+ or -] SDS; range) (2.74-8.90) Gestational age (weeks) 36.93 [+ or -] 4.61 (mean [+ or -] SDS) Apgar 1 min (mean [+ or -] SDS) * 4.58 [+ or -] 3.02 Apgar 5 min (mean [+ or -] SDS) * 6.25 [+ or -] 2.56 Birth weight (kg) (mean [+ or -] SDS) 2.65 [+ or -] 0.85 GMFCS (III, IV, V) (%) 68, 27, 5 Use of antiepileptic medication (%) 77% Group B Num.
The Gross Motor Function Classification System (GMFCS) classifies the seriousness of the condition in five levels: patients classified with levels I and II present mild moto impairment and are able to walk; at level III the impairment is moderate and aids are required for walking; patients with levels IV and V present major motor impairment and require a wheelchair for moving (2,4).
Acronyms browser ?
Full browser ?
- Gmerlin Audio Video Library
- GMF Network Control Center
- GMF Network Controller
- GMF SATCOM
- GMFSC Network Controller